Vote Scores

Home / Companies / Amgen Inc. / 19 May 2026

Meeting · year to 30 June 20261,861 filers reporting

Amgen Inc.: meeting of 19 May 2026

Votes reported on Form N-PX, item by item

1,861 Form N-PX filers reported votes at the Amgen Inc. meeting of 19 May 2026. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

12 nominees; 95.2% of reported votes for; 34 filers withheld from or voted against at least one nominee.

14,982 vote records from 418 filers. 3 of the 417 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.3% for0.5% against1.2% other0.7% against management418 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

3,227 vote records from 1,843 filers. 72 of the 1,797 filers that marked the item either way voted against management. 46 filers reported this item without a management mark.

93.1% for4.0% against2.9% other4.0% against management1,843 filers98.6% for1.2% against0.2% other1.3% against management526,023,918 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

1,249 vote records from 414 filers. 14 of the 413 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

96.1% for3.1% against0.7% other3.4% against management414 filers99.4% for0.6% against0.0% other0.5% against management199,829,457 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

62 vote records from 26 filers. 1 of the 26 filers that marked the item either way voted against management.

100.0% for0.0% against3.8% against management26 filers100.0% for0.0% against0.0% other1.5% against management558,290 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCESecurity holder

Stockholder proposal to require an independent board chairman.

1,209 vote records from 400 filers. 88 of the 398 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

21.3% for77.8% against1.0% other22.1% against management400 filers2.9% for97.1% against0.0% other2.9% against management199,154,967 reported shares
6

Several categoriesSecurity holder

Shareholder proposals (not separable from the filings)

Filers described these proposals in wordings that could not be matched to one another, so they are shown together.

5 vote records from 5 filers. 2 of the 5 filers that marked the item either way voted against management.

20.0% for80.0% against40.0% against management5 filers60.3% for39.7% against62.2% against management8,827 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor5. Proposal
VanguardForForForAgainst
BlackRock and iSharesForForForAgainst
FidelityForForForAgainst
DimensionalForForForAgainst
State Street and SPDRForForForAgainst
American CenturyForForForAgainst
Franklin TempletonForForForAgainst
InvescoForForForAgainst
EquitableForForForAgainst
Charles SchwabForForForAgainst
Nuveen and TIAAForForForAgainst
ProShares and ProFundsForForForAgainst
John Hancock and ManulifeForForForAgainst
Morgan Stanley, Eaton Vance and CalvertForForForAgainst
J.P. MorganForForForAgainst
Goldman SachsForForForAgainst
WisdomTreeForForForAgainst
PGIM and PrudentialForForForFor *
Jackson National fundsForForForAgainst
Northern Trust and FlexSharesForForForAgainst
SEIForForForFor *
T. Rowe PriceForForForAgainst
ThriventForForForAgainst
Lincoln FinancialForForForAgainst
VoyaForForForAgainst
First TrustForForForAgainst
Russell InvestmentsForForForFor *
NationwideForForForAgainst
Victory CapitalForForForAgainst
Brighthouse FundsForForForAgainst *
Guggenheim and RydexForForForAgainst
Columbia ThreadneedleForForForFor *
BNY MellonForForForAgainst
PrincipalForForForAgainst
Capital Group and American FundsForForForAgainst
Pacific Life fundsForForForAgainst
Global XForForForFor *
TransamericaForForForAgainst
Federated HermesForForForFor *
AllianceBernsteinForForForAgainst
Hartford FundsForForForFor *
DWSForForForAgainst
PIMCOForForForFor *
AllspringForForForAgainst
MassMutualForForForFor *
Harbor FundsForForForAgainst
VirtusForForForAgainst
VanEckForForForFor *
Macquarie and Delaware FundsForForForAgainst
Janus HendersonForForForFor *
Neuberger BermanForForForFor *
American BeaconForForForAgainst
Natixis and Loomis SaylesForForForAgainst
Cohen & SteersNo reportForNo reportNo report
Dodge & CoxNo reportForNo reportNo report
Harris Associates and OakmarkNo reportForNo reportNo report
BairdNo reportForNo reportNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Amgen Inc. meeting?

1,861 Form N-PX filers reported votes at the meeting of 19 May 2026. On say-on-pay, 72 of 1,797 voted against management (4.0%). One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Amgen Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Amgen Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Amgen Inc. with a meeting date within three days of 19 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.